AKT1 and glioblastoma: However, temozolomide, gold standard of GBM treatment which activates Wnt/β-catenin signaling through the PI3K/AKT pathway (157), potentially counteract OVT in combination with G47Δ-mIL12 (an HSV-1 variant) (158).